Multiple sclerosis trials in China
28 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.
- Early phase 1Taking peopleSafety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System
- Where
- Wuhan
- Age
- 18 years to 75 years
- People
- 36
- Run by
- Tongji Hospital
See details and how to joinNCT04561557 - No phaseTaking peopleEfficacy and Safety of Calculus Bovis Sativus (CBS) for Idiopathic Inflammatory Demyelinating Disease (CBSinIIDD)
- Where
- Wuhan
- Age
- 18 years and over
- People
- 250
- Run by
- Tongji Hospital
See details and how to joinNCT06474520 - No phaseTaking peopleSun Yat-Sen Cohort of CNS Idiopathic Inflammatory Demyelinating Diseases
- Where
- Guangzhou
- Age
- 18 years to 65 years
- People
- 450
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT06541626